Twist Bioscience Secures $31.1 Million

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company’s semiconductor-based synthetic gene manufacturing process. Nick and Joby Pritzker, through their family’s firm Tao Invest, led the round, with participation from ARCH Venture Partners, Paladin Capital Group, Yuri Milner and additional strategic corporate and venture investors.

Damballa Raises $13 Million for Global Expansion

Damballa has raised $13 million from existing investors to capitalize on growing demand for its automated breach defenseplatform. The company will leverage the additional funds for North American and international sales expansion, as well as marketing and channel efforts. The fundraising comes on the heels of the company’s best year to date in 2013, and a record Q1 2014.

PhishMe Reports Third Consecutive Year of Extraordinary Growth

PhishMe Inc., creator of the industry-leading phishing mitigation and detection platform, today reported extraordinary corporate performance for the 2013 fiscal year. Bookings grew 130% over the previous year and the company achieved significant increases across all key corporate performance measures, including the largest fourth quarter in company history.

Page 45 of 50« First...102030...4344454647...50...Last »